Workflow
NEWAY(603699)
icon
Search documents
纽威股份(603699) - 纽威股份第五届监事会第二十二次会议决议的公告
2025-07-01 10:15
证券代码:603699 证券简称:纽威股份 公告编号:临 2025-045 苏州纽威阀门股份有限公司 第五届监事会第二十二次会议决议的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 苏州纽威阀门股份有限公司(以下简称"公司")第五届监事会第二十二次会 议于 2025 年 06 月 25 日以电子邮件、电话通知的方式发出会议通知,于 2025 年 07 月 01 日上午在公司会议室以现场结合通讯表决方式召开,应到监事 3 名, 实到监事 3 名。会议由监事会主席邹琴女士主持,会议的召开符合有关法律、行 政法规、部门规章、规范性文件和公司章程的规定。 二、监事会会议审议情况 会议审议了以下议案: 1、审议并通过《关于公司 2025 年限制性股票激励计划(草案)的议案》; 为了进一步建立、健全公司长效激励机制,吸引和留住优秀人才,充分调动 公司(含分、子公司)董事、高级管理人员、中层管理人员及核心技术(业务) 骨干的积极性,有效地将股东利益、公司利益和核心团队个人利益结合在一起, 使各方共同关注公司的长 ...
纽威股份(603699) - 纽威股份监事会关于公司2025年限制性股票激励计划(草案)相关事项的核查意见
2025-07-01 10:15
苏州纽威阀门股份有限公司 (2)最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无 法表示意见的审计报告; (3)上市后最近36个月内出现过未按法律法规、公司章程、公开承诺进行 利润分配的情形; (4)法律法规规定不得实行股权激励的; (5)中国证监会认定的其他情形。 监事会关于公司 2025 年限制性股票激励计划(草案) 相关事项的核查意见 苏州纽威阀门股份有限公司(以下简称"公司")监事会根据《中华人民共和 国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》(以下简称 "《证券法》")、《上市公司股权激励管理办法》(以下简称"《管理办法》") 等有关法律、法规和规范性文件及《公司章程》的规定,对《苏州纽威阀门股份 有限公司 2025 年限制性股票激励计划(草案)》(以下简称"《激励计划(草案)》") 及相关事项进行了必要的核查,现发表核查意见如下: 一、关于公司《2025 年限制性股票激励计划(草案)》及其摘要的核查意见 1、公司不存在《管理办法》等法律、法规规定的禁止实施限制性股票的情 形,包括: (1)最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报 ...
纽威股份(603699) - 纽威股份第五届董事会第二十九次会议决议的公告
2025-07-01 10:15
证券代码:603699 证券简称:纽威股份 公告编号:临 2025-044 苏州纽威阀门股份有限公司 第五届董事会第二十九次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 苏州纽威阀门股份有限公司(以下简称"公司")第五届董事会第二十九次会 议于 2025 年 06 月 25 日以电子邮件、电话通知的方式发出会议通知,于 2025 年 07 月 01 日上午在公司会议室以现场结合通讯表决方式召开。本次会议应参加董 事 7 名,实际参加董事 7 名。会议由董事长鲁良锋先生主持,公司全体监事、董 事会秘书及其他部分高级管理人员列席了会议。会议的召集、召开及表决程序符 合有关法律、法规、部门规章、规范性文件和公司章程的规定,会议程序合法、 有效。 二、董事会会议审议情况 本次会议经与会董事认真审议,以投票表决方式做出如下决议: 1、 审议通过《关于公司 2025 年限制性股票激励计划(草案)的议案》; 为了进一步建立、健全公司长效激励机制,吸引和留住优秀人才,充分调动 公司(含分、子公司)董事 ...
7月度金股:指数搭台,成长唱戏-20250630
Soochow Securities· 2025-06-30 01:33
Core Insights - The report emphasizes a focus on the technology sector for investment opportunities, particularly in growth stocks, as the market index has shown upward momentum [2][6]. - The report outlines a selection of ten key stocks, highlighting their respective industries, market capitalizations, earnings per share (EPS) forecasts, and price-to-earnings (PE) ratios for 2026 and 2027 [2][68]. Group 1: Key Stock Recommendations - **Neway Valve (603699.SH)**: A leading global industrial valve manufacturer, benefiting from a surge in LNG and marine engineering sectors, with expected overseas order growth of over 50% year-on-year in the first half of 2025 [11][12]. - **Yongxing Environmental (601033.SH)**: The sole operator of waste incineration in Guangzhou, with a projected capacity utilization rate of 79% and a commitment to high dividends, expecting a 174% increase in free cash flow in 2024 [17][18]. - **Aerospace Electronics (600879.SH)**: Focused on aerospace electronics and unmanned systems, with anticipated high growth driven by the commercial space industry and demand for satellite communication technologies [26][27]. - **Miaokelando (600882.SH)**: Positioned for long-term growth in the dairy sector, with a focus on product innovation and cost management, expecting significant revenue growth in the upcoming quarters [31][32]. - **Laopu Gold (6181.HK)**: A high-end gold jewelry brand with strong revenue growth, projected to achieve 8.51 billion yuan in revenue in 2024, benefiting from the expanding market for traditional gold products [36][38]. - **Jingzhida (688627.SH)**: Engaged in the semiconductor testing equipment sector, with significant market potential and expected strong performance due to key customer orders [42][43]. - **Shensanda A (000032.SZ)**: Positioned to benefit from the increasing demand for AI infrastructure and applications, with a strong foothold in public data services [47][48]. - **Sanqi Interactive (002555.SZ)**: Anticipating strong performance from new game releases, particularly the upcoming "Douluo Dalu: Hunting Soul World," with high player interest [53][56]. - **CATL (300750.SZ)**: Expected to maintain strong profit growth, with projected net profits of 66.1 billion yuan in 2025, driven by increasing demand for electric vehicle batteries [59][60]. - **Borui Pharmaceutical (688166.SH)**: Forecasted to achieve net profits of 2.6 billion yuan in 2025, with significant potential in the Amylin pipeline, which has attracted substantial investment interest [63][64]. Group 2: Financial Data Overview - The report provides detailed financial forecasts for the ten key stocks, including projected revenues and net profits for 2025 to 2027, highlighting the growth potential across various sectors [68]. - For instance, Neway Valve is expected to generate 74.53 billion yuan in revenue in 2025, with a net profit of 14.49 billion yuan, reflecting strong operational performance [68]. - CATL's projected revenue for 2025 is 472.43 billion yuan, with a net profit forecast of 66.13 billion yuan, indicating robust growth in the electric vehicle battery market [68].
6月27日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-27 10:35
Group 1 - Hengbang Co., Ltd. plans to establish a joint venture with Huasheng Development with a registered capital of 10 million yuan, where Hengbang will contribute 8 million yuan (80%) and Huasheng will contribute 2 million yuan (20%) [1] - Hunan Gold's subsidiary Anhua Zhazi Creek Smelting Plant will undergo temporary maintenance starting from the end of June 2025, expected to last no more than 30 days [2] - Defu Technology's subsidiary signed supply agreements for lithium battery copper foil products with two leading global companies, with contract durations of 3 years and 5 years respectively [3] Group 2 - Binjiang Group won the rights to two residential land parcels for a total price of 4.368 billion yuan [5] - Zhong'an Technology announced the resignation of its executive vice president and board secretary due to personal reasons [7] - Changqing Technology's project for special polymer materials and electronic materials has officially commenced production, adding a capacity of 120,500 tons per year [10] Group 3 - Gansu Energy received approval from the China Securities Regulatory Commission to publicly issue bonds totaling up to 2 billion yuan [10] - Shuoshi Biology obtained a medical device registration certificate for an in vitro diagnostic reagent, valid until June 2030 [12] - Yawen Co., Ltd. plans to issue shares to specific investors, with the application accepted by the Shenzhen Stock Exchange [13] Group 4 - Guoyao Modern's subsidiary received approval for the listing of a raw material drug, which is a selective anticholinergic agent [16] - Inner Mongolia First Machinery's subsidiary signed a railway freight car procurement contract worth 130 million yuan [18] - Xining Special Steel plans to raise up to 1 billion yuan through a private placement to its controlling shareholder [39] Group 5 - Huadong Medicine's subsidiary received approval for a clinical trial of a new injectable drug targeting advanced solid tumors [29] - Warner Pharmaceutical's compound potassium hydrogen phosphate injection passed the consistency evaluation for generic drugs [30] - North Special Technology plans to raise up to 300 million yuan through a private placement for a production base project in Thailand [30] Group 6 - Xiangyang Technology is the first candidate for a 533 million yuan Airbus project [45] - Haishun New Materials intends to acquire 100% of Guangdong Zhengyi Packaging [46] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.73% due to personal financial needs [47]
纽威股份实控人全资公司拟减持 去年净利增速远超营收
Zhong Guo Jing Ji Wang· 2025-06-27 03:48
Group 1 - The controlling shareholder, Niuwei Group, plans to reduce its stake in Niuwei Co., Ltd. by up to 7,490,620 shares, representing 0.97% of the total share capital, through centralized bidding within three months after the announcement [1][2] - The implementation of the share reduction plan is subject to market conditions and the company's stock price, indicating uncertainty in the timing and pricing of the reduction [2] - Niuwei Co., Ltd. reported a revenue of 6.238 billion yuan in 2024, a year-on-year increase of 12.50%, and a net profit attributable to shareholders of 1.156 billion yuan, reflecting a significant growth of 60.10% [3][4] Group 2 - The company achieved a net cash flow from operating activities of 1.112 billion yuan in 2024, marking a 74.50% increase compared to the previous year [3][4] - In the first quarter of 2025, Niuwei Co., Ltd. reported a revenue of 1.556 billion yuan, a year-on-year growth of 14.44%, and a net profit of 263 million yuan, up 33.52% [5][6] - The company plans to distribute a cash dividend of 1.14 yuan per share, totaling approximately 876 million yuan, based on a total share capital of 768,573,661 shares [4]
纽威股份: 纽威股份控股股东的一致行动人集中竞价减持股份计划公告
Zheng Quan Zhi Xing· 2025-06-26 16:34
Core Viewpoint - The announcement details a share reduction plan by the controlling shareholder, Niuwei Group, which intends to sell up to 7,490,620 shares, representing 0.97% of the total share capital, through centralized bidding within a specified period [1][2]. Shareholder Information - As of the announcement date, Niuwei Group holds 7,490,620 shares, accounting for 0.97% of the company's total share capital, with shares acquired prior to the IPO [1]. - The controlling shareholders include Wang Baoqing, Lu Bin, Cheng Zhangwen, and Xi Chao, who collectively hold significant stakes and have signed an "Action Agreement" confirming their unified control over the company [1]. Reduction Plan Details - The planned reduction will occur from July 18, 2025, to October 17, 2025, with the selling price determined by market conditions [2]. - The reason for the share reduction is stated as a need for shareholder funds [2]. - Niuwei Group has previously made commitments regarding shareholding, including a 36-month lock-up period post-IPO, which has been adhered to [2][3]. Compliance and Risk - The share reduction plan is consistent with prior commitments made by Niuwei Group and complies with relevant regulations [3]. - The company will monitor the implementation of the reduction plan and fulfill its disclosure obligations as required by law [3].
纽威股份(603699) - 纽威股份控股股东的一致行动人集中竞价减持股份计划公告
2025-06-26 10:17
| 股东名称 | 纽威集团有限公司 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | √是 | □否 | | | 直接持股 5%以上股东 | □是 | √否 | | | 董事、监事和高级管理人员 | □是 | √否 | | | 其他:无 | | | | 持股数量 | 7,490,620股 | | | | 持股比例 | 0.97% | | | | 当前持股股份来源 | IPO 前取得:7,490,620股 | | | 一、减持主体的基本情况 上述减持主体存在一致行动人: | | | 证券代码:603699 证券简称:纽威股份 公告编号:临 2025-043 苏州纽威阀门股份有限公司 控股股东的一致行动人 集中竞价减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 1 股东持股的基本情况:截至本公告日,股东纽威集团有限公司(以下 简称"纽威集团")持有公司股份 7,490,620 股,占公司总股本的 0.97%; 股份来源为 ...
纽威股份:纽威集团拟减持不超0.97%公司股份
news flash· 2025-06-26 09:52
纽威股份(603699)公告,股东纽威集团计划通过集中竞价交易方式减持公司股份不超过749.06万股, 占公司总股本的0.97%。 ...
中国石油举办投资者反向路演活动
Jing Ji Wang· 2025-06-23 09:24
Core Insights - The event aimed to enhance value management for listed companies under China National Petroleum Corporation (CNPC) and involved a reverse roadshow in Xinjiang with participation from various investment institutions [1][2][3] - Investors expressed confidence in CNPC's ability to integrate traditional and renewable energy, innovate in refining and chemical sectors, and expand its sales network, indicating a strong belief in the company's future high-quality development [1][2] Group 1: Investor Engagement - A total of 28 investors from 26 domestic and international institutions participated in the roadshow, visiting key operational sites such as Xinjiang Oilfield and Karamay Petrochemical [1] - Investors showed significant interest in innovative projects like the world's first SAGD heavy oil tower-type thermal extraction and high-temperature solar thermal coupling project [1][2] Group 2: Company Achievements - Karamay Petrochemical and Dushanzi Petrochemical have made substantial progress in "reducing oil and increasing chemicals," maintaining high profitability during the refining industry's downturn [2] - The Kunlun Energy Xinjiang Company received high praise for its efforts in natural gas terminal utilization and its role in local economic development [2] Group 3: Future Plans - The company plans to continue enhancing its investor relations management system, focusing on strategic development, communication, brand image, and shared operational success with investors [3]